Month: July 2023

Beauty-Stem Biomedical’s Medical Seminar Unveils Remarkable Link Between CD34 Stem Cells and Human Well-Being: Regeneration, Immune Enhancement and Hematopoiesis

LOS ANGELES, July 28, 2023 (Newswire.com)
–
Ryan Huang, CEO of Beauty-Stem Biomedical, and Dr. David Chen, director of Diagnostic Medical Group of Southern California, delivered a compelling presentation highlighting the numerous benefits of CD34 stem cells. Together, they introduced the concept of “Health Deposit” to the public, emphasizing the critical importance of maintaining optimal CD34 stem cell counts for overall health and well-being.

“CD34 stem cells can be aptly described as the deposit of a Health Saving Account, where the principle is simple: the more CD34 stem cells an individual possesses, the greater their physical well-being,” said Ryan Huang, CEO of Beauty-Stem Biomedical.  

Dr. David Chen has listed three major contributions of CD34 Stem cells to human well-being. “Countless clinical data and publish has proved that maintaining higher levels of CD34 stem cells can have significant health benefits.”

1. Regeneration: CD34 stem cells have regenerative properties, meaning they can differentiate into different cell types and help repair damaged tissues and organs. When introduced into injured areas, they can promote tissue repair and regeneration.
2. Immune Enhancement: CD34 stem cells can contribute to immune enhancement by giving rise to immune cells, such as natural killer (NK) cells, which play a critical role in the body’s defense against infections, cancers, and other foreign invaders.
3. Hematopoiesis: CD34 stem cells play a crucial role in hematopoiesis, the process by which all types of blood cells are produced. They are responsible for generating various blood cell lineages, including red blood cells, white blood cells, and platelets. This essential function ensures a steady supply of healthy blood cells, which are vital for oxygen transport, immune response, and clotting.

Beauty-Stem Biomedical encourages individuals to quantitate their own “Health Deposit” by testing their CD34 stem cell counts. Knowing the levels of these powerful cells can provide valuable insights into overall health and well-being, empowering proactive measures to boost immune function. ⁠⁠⁠⁠⁠⁠ 

Contact Information:

Kaihsiang Lee

Marketing Manger

[email protected]

888-341-7505

Original Source:

Beauty-Stem Biomedical Holds Successful CD34 Stem Cell Medical Symposium Exploring Regenerative Trend ‘CD34 Health Deposit’

The post Beauty-Stem Biomedical Holds Successful CD34 Stem Cell Medical Symposium Exploring Regenerative Trend ‘CD34 Health Deposit’ first appeared on Enrose Magazine.

The post Beauty-Stem Biomedical Holds Successful CD34 Stem Cell Medical Symposium Exploring Regenerative Trend ‘CD34 Health Deposit’ appeared first on IGP Beauty.

Unify Medical, Inc., a privately-held, smart, surgical visualization technology company, announced it has entered into a know-how agreement with Mayo Clinic to assess and develop clinical applications using Unify’s fluorescence-guided visualization technology

SCOTTSDALE, Ariz., July 28, 2023 (Newswire.com)
–
Unify Medical, Inc., a privately-held, smart, surgical visualization technology company, announced it has entered into a know-how agreement with Mayo Clinic to assess and develop clinical applications using Unify’s fluorescence-guided visualization technology.

Michael Kendrick, MD, Chair of the Department of Surgery, Mayo Clinic, will be the principal investigator. This collaboration will leverage Unify Medical’s wearable fluorescence-guided, surgical device technology for pancreatic cancer applications.

“We believe this collaboration will aid in the advancement of specific applications for pancreatic cancer,” said Rick Kovach, CEO of Unify Medical.

About Fluorescence-guided Surgery

To date, surgeons have faced limitations in confidently assessing the location and full extent of cancerous tissue while operating. Unify Medical’s fluorescent visualization technology will allow surgeons to see tissue perfusion and optimize surgical planning.

Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit missions in patient care, education, and research.

About Unify Medical, Inc.

Unify Medical develops several surgical visualization technologies, including fluorescence-imaging solutions. The Company’s first product is currently under development for use during multiple surgical applications and is not yet FDA-approved. For more information, visit www.unifymedical.com.

Contact Information:

Rick Kovach

President & CEO

[email protected]

Original Source:

Unify Medical Announces Know-How Agreement With Mayo Clinic for Fluorescence-Guided Visualization

The post Unify Medical Announces Know-How Agreement With Mayo Clinic for Fluorescence-Guided Visualization first appeared on Enrose Magazine.

The post Unify Medical Announces Know-How Agreement With Mayo Clinic for Fluorescence-Guided Visualization appeared first on IGP Beauty.

Glidewell Receives PDAC-Approval for Silent Nite Sleep Appliance, Making It the Second Silent Nite Appliance Eligible for Medicare Reimbursement Using Code E0486

…

The post The Glidewell Silent Nite Sleep Appliance is Now PDAC-Approved for Medicare (E0486) first appeared on Enrose Magazine.

The post The Glidewell Silent Nite Sleep Appliance is Now PDAC-Approved for Medicare (E0486) appeared first on IGP Beauty.